Related Experiment Videos
Mediastinal lymph node hyperplasia, hypergammaglobulinemia, and anemia
The Journal of Thoracic and Cardiovascular Surgery
|June 1, 1980
Summary
Surgical removal of mediastinal giant lymph node hyperplasia cured anemia and improved development in an adolescent girl. This condition can cause immune issues and anemia in children.
Area of Science:
- Pediatric Endocrinology
- Pediatric Hematology
- Immunology
Background:
- Mediastinal giant lymph node hyperplasia (MGLNH) is a rare condition.
- It can present with varied clinical manifestations, including anemia and immune disturbances.
Observation:
- An adolescent female presented with retarded development, delayed puberty, and anemia unresponsive to iron therapy.
- A surgically removed mediastinal mass, identified as MGLNH with abundant plasma cells, resolved the anemia.
Findings:
- Post-operative follow-up revealed accelerated growth and development of secondary sexual characteristics.
- Long-term (20-year) follow-up showed compensated increased erythrocyte hemolysis and elevated serum IgM.
Implications:
- MGLNH in childhood, especially with plasma cells, should be considered in cases of refractory anemia and immune dysfunction.
- Surgical resection may be curative, leading to significant long-term improvements in growth and development.